* Precigen Inc PGEN.OQ PGEN.O is expected to show a fall
in
quarterly revenue when it reports results
* The Germantown Maryland-based company is expected to
report a
88.2% decrease in revenue to $1.98 million from $16.72 million a
year ago, according to the mean estimate from 5 analysts, based
on LSEG data.
* Refinitiv's mean analyst estimate for Precigen Inc is for
a
loss of 8 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Precigen
Inc is
$9, above its last closing price of $1.11.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 -0.10 -0.10 -0.08 Beat 20
Mar. 31 2023 -0.10 -0.09 -0.10 Missed -9.6
Dec. 31 2022 -0.10 -0.10 -0.11 Missed -10
Sep. 30 2022 0.00 0.02 -0.04 Missed -340
Jun. -0.15 -0.13 -0.09 Beat 31.8
30 2022
Mar. 31 2022 -0.14 -0.13 -0.10 Beat 21.6
Dec. 31 2021 -0.14 -0.14 -0.13 Beat 4.4
Sep. 30 2021 -0.15 -0.14 -0.15 Missed -5.9
This summary was machine generated November 3 at 11:50 GMT. All
figures in US dollars unless otherwise stated